Results 141 to 150 of about 7,400,368 (352)
A long‐term data set for hydrologic modeling in a snow‐dominated mountain catchment [PDF]
Michele L. Reba +5 more
openalex +1 more source
NuCDS: An Efficient Local Search Algorithm for Minimum Connected Dominating Set [PDF]
Bohan Li +5 more
openalex +1 more source
Nanosecond infrared laser (NIRL) low‐volume sampling combined with shotgun lipidomics uncovers distinct lipidome alterations in oropharyngeal squamous cell carcinoma (OPSCC) of the palatine tonsil. Several lipid species consistently differentiate tumor from healthy tissue, highlighting their potential as diagnostic markers.
Leonard Kerkhoff +11 more
wiley +1 more source
A Note on Non-Dominating Set Partitions in Graphs
A set S of vertices of a graph G is a dominating set if every vertex not in S is adjacent to a vertex of S and is a total dominating set if every vertex of G is adjacent to a vertex of S.
Desormeaux Wyatt J. +2 more
doaj +1 more source
Polyhedra Associated with Open Locating-Dominating and Locating Total-Dominating Sets in Graphs
Gabriela R. Argiroffo +3 more
openalex +2 more sources
Graphs with unique Grundy dominating sets [PDF]
Boštjan Brešar, Tanja Dravec
openalex +1 more source
This study shows that copy number variations (CNVs) can be reliably detected in formalin‐fixed paraffin‐embedded (FFPE) solid cancer samples using ultra‐low‐pass whole‐genome sequencing, provided that key (pre)‐analytical parameters are optimized.
Hanne Goris +10 more
wiley +1 more source
Dominating Sets of Random 2-in 2-out Directed Graphs [PDF]
Stephen M Howe
openalex +1 more source
Single circulating tumor cells (sCTCs) from high‐grade serous ovarian cancer patients were enriched, imaged, and genomically profiled using WGA and NGS at different time points during treatment. sCTCs revealed enrichment of alterations in Chromosomes 2, 7, and 12 as well as persistent or emerging oncogenic CNAs, supporting sCTC identity.
Carolin Salmon +9 more
wiley +1 more source
Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang +3 more
wiley +1 more source

